NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 96 filers reported holding NGM BIOPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $149,435 | -48.7% | 139,659 | +95.5% | 0.00% | -100.0% |
| Q1 2023 | $291,487 | -41.2% | 71,443 | -27.7% | 0.00% | -50.0% |
| Q4 2022 | $495,810 | +46.3% | 98,767 | +281.1% | 0.00% | 0.0% |
| Q3 2022 | $339,000 | -42.6% | 25,914 | -33.1% | 0.00% | -33.3% |
| Q1 2022 | $591,000 | +224.7% | 38,747 | +277.4% | 0.00% | – |
| Q4 2021 | $182,000 | -46.2% | 10,266 | -36.1% | 0.00% | -100.0% |
| Q3 2021 | $338,000 | -23.2% | 16,076 | -27.9% | 0.00% | -50.0% |
| Q2 2021 | $440,000 | -37.1% | 22,296 | -7.3% | 0.00% | -50.0% |
| Q1 2021 | $699,000 | +11.8% | 24,039 | +16.6% | 0.00% | -20.0% |
| Q4 2020 | $625,000 | +7.2% | 20,618 | -30.2% | 0.01% | -44.4% |
| Q2 2020 | $583,000 | – | 29,525 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 3,766,666 | $79,175,000 | 44.14% |
| Ponoi II Management, LLC | 1,298,908 | $27,303,000 | 40.46% |
| Column Group LLC | 15,396,116 | $323,626,000 | 36.81% |
| Ponoi Management, LLC | 1,298,908 | $27,303,000 | 24.24% |
| Euclidean Capital LLC | 832,274 | $17,494,000 | 8.50% |
| StepStone Group LP | 1,573,357 | $33,072,000 | 2.14% |
| Octagon Capital Advisors LP | 200,000 | $4,204,000 | 1.04% |
| Redmile Group, LLC | 2,505,118 | $52,658,000 | 0.92% |
| BVF INC/IL | 955,000 | $20,074,000 | 0.78% |
| Boxer Capital, LLC | 500,000 | $10,510,000 | 0.37% |